Our results are aligned with prior investigations demonstrating increased ACE2/TMPRSS2 expression in capillaries of COVID-19 patients (25), and therefore support capillaritis as a prominent mediator of viral-induced myocardial injury. The gene discussed is ACE2; the disease is COVID-19.